A detailed history of Morgan Stanley transactions in Forian Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,500 shares of FORA stock, worth $5,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,500
Previous 2,500 -0.0%
Holding current value
$5,300
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024

SELL
$2.51 - $3.06 $1,475 - $1,799
-588 Reduced 19.04%
2,500 $6,000
Q2 2024

Aug 14, 2024

SELL
$2.51 - $3.06 $1,475 - $1,799
-588 Reduced 19.04%
2,500 $6,000
Q1 2024

Oct 17, 2024

BUY
$2.53 - $3.69 $1,487 - $2,169
588 Added 23.52%
3,088 $10,000
Q1 2024

Aug 16, 2024

BUY
$2.53 - $3.69 $1,487 - $2,169
588 Added 23.52%
3,088 $10,000
Q1 2024

May 15, 2024

BUY
$2.53 - $3.69 $7,812 - $11,394
3,088 New
3,088 $10,000
Q1 2023

May 15, 2023

BUY
$2.29 - $5.2 $1,346 - $3,057
588 Added 1547.37%
626 $2,000
Q4 2022

Feb 14, 2023

SELL
$2.15 - $3.9 $3,470 - $6,294
-1,614 Reduced 97.7%
38 $0
Q3 2022

Nov 14, 2022

SELL
$3.35 - $6.18 $37,684 - $69,518
-11,249 Reduced 87.19%
1,652 $5,000
Q2 2022

Oct 27, 2022

BUY
$2.84 - $6.75 $27,170 - $64,577
9,567 Added 286.95%
12,901 $56,000
Q2 2022

Aug 15, 2022

BUY
$2.84 - $6.75 $27,170 - $64,577
9,567 Added 286.95%
12,901 $56,000
Q1 2022

Oct 27, 2022

SELL
$5.78 - $8.53 $55,297 - $81,606
-9,567 Reduced 74.16%
3,334 $24,000
Q1 2022

May 13, 2022

SELL
$5.78 - $8.53 $65,146 - $96,141
-11,271 Reduced 77.17%
3,334 $24,000
Q4 2021

Feb 14, 2022

BUY
$7.85 - $11.3 $92,009 - $132,447
11,721 Added 406.41%
14,605 $133,000
Q3 2021

Nov 15, 2021

BUY
$9.89 - $12.73 $28,522 - $36,713
2,884 New
2,884 $30,000

Others Institutions Holding FORA

About Forian Inc.


  • Ticker FORA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 32,644,800
  • Market Cap $69.2M
  • Description
  • Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a...
More about FORA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.